ArticleFrontiers in oncology2022

Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy.

Wei-Ting Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.